Table 1 Demographic and clinical differences at baseline between Never and Ever erosive patients
From: Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
Never erosive | Ever erosive | Diff | |||
|---|---|---|---|---|---|
n = 144 | n = 464 | ||||
Mean (SD) | n (%) | Mean (SD) | n (%) | p-value | |
Inclusion age | 52 (15) | 55 (13) | 0.006 | ||
Female gender | 94 (65) | 320 (69) | 0.41 | ||
Dis dur, months | 6 (3) | 6 (3) | 0.15 | ||
RF | 64 (44) | 316 (69) | 0.001 | ||
Anti- CCP | 36 (31) | 217 (70) | 0.001 | ||
Current smoker | 31 (22) | 126 (27) | 0.20 | ||
DAS28 | 4.9 (1.4) | 5.1 (1.2) | 0.16 | ||
SJC28 | 9 (6) | 10 (6) | 0.08 | ||
TJC28 | 8 (7) | 7 (6) | 0.050 | ||
PatGA | 45 (27) | 45 (25) | 0.97 | ||
Pain | 45 (25) | 47 (25) | 0.34 | ||
ESR | 26 (21) | 34 (24) | 0.001 | ||
HAQ | 0.91 (0.66) | 0.90 (0.59) | 0.91 | ||
SHS | 0.40 (1.51) | 7.19 10.52) | 0.001 | ||
Erosion score | 0 | 2.52 (4.07) | na | ||
JSN | 0.44 (1.58) | 4.68 (7.79) | 0.001 | ||